Dexlansoprazole



Indications and Reactions:

Role Indications Reactions
Primary
Gastrooesophageal Reflux Disease 41.2%
Cerebrovascular Accident Prophylaxis 11.8%
Ischaemic Heart Disease Prophylaxis 11.8%
Prophylaxis 11.8%
Dyspepsia 5.9%
Gastritis 5.9%
Influenza Like Illness 5.9%
Product Used For Unknown Indication 5.9%
Diarrhoea 12.5%
Nephrolithiasis 12.5%
Treatment Noncompliance 12.5%
Drug Interaction 6.3%
Hospitalisation 6.3%
Macrocytosis 6.3%
Myocardial Infarction 6.3%
Nervous System Disorder 6.3%
Oedema Peripheral 6.3%
Pruritus 6.3%
Septic Shock 6.3%
Skin Hypopigmentation 6.3%
Vomiting 6.3%
Secondary
Gastrooesophageal Reflux Disease 18.1%
Bipolar Disorder 7.4%
Hypertension 7.4%
Oesophageal Disorder 7.4%
Anxiety 6.4%
Depression 6.4%
Dyspepsia 6.4%
Panic Attack 6.4%
Nervousness 4.3%
Panic Disorder 4.3%
Stress 4.3%
Arthritis 3.2%
Sleep Disorder 3.2%
Agitation 2.1%
Asthma 2.1%
Atrial Fibrillation 2.1%
Barrett's Oesophagus 2.1%
Flatulence 2.1%
Insomnia 2.1%
Nervous System Disorder 2.1%
Ulcer 14.8%
Pharyngeal Haemorrhage 7.4%
Somnolence 7.4%
Toxic Epidermal Necrolysis 7.4%
Visual Impairment 7.4%
Weight Decreased 7.4%
Abdominal Discomfort 3.7%
Abdominal Pain Upper 3.7%
Adverse Drug Reaction 3.7%
Feeling Abnormal 3.7%
Insomnia 3.7%
Ischaemic Stroke 3.7%
Lung Disorder 3.7%
Palpitations 3.7%
Priapism 3.7%
Rash 3.7%
Throat Irritation 3.7%
Thrombosis 3.7%
Vomiting 3.7%
Concomitant
Product Used For Unknown Indication 37.4%
Hypertension 8.2%
Gastrooesophageal Reflux Disease 8.1%
Osteoporosis 6.4%
Depression 5.9%
Pain 4.9%
Crohn's Disease 3.8%
Anxiety 3.3%
Nausea 2.3%
Fibromyalgia 2.2%
Migraine 2.2%
Diabetes Mellitus 2.1%
Blood Cholesterol Increased 2.0%
Bipolar Disorder 1.8%
Rheumatoid Arthritis 1.8%
Chest Pain 1.7%
Chronic Obstructive Pulmonary Disease 1.6%
Pulmonary Arterial Hypertension 1.6%
Gastric Disorder 1.5%
Hypothyroidism 1.3%
Bronchiectasis 8.8%
Pain 7.0%
Vomiting 7.0%
Dyspnoea 6.1%
Nausea 6.1%
Drug Ineffective 5.3%
Fatigue 5.3%
Palpitations 5.3%
Rash 5.3%
Weight Decreased 5.3%
Death 4.4%
Somnolence 4.4%
Urinary Tract Infection 4.4%
Vertigo 4.4%
Abdominal Pain 3.5%
Pyrexia 3.5%
Swollen Tongue 3.5%
Vision Blurred 3.5%
White Blood Cell Count Decreased 3.5%
Wrong Technique In Drug Usage Process 3.5%
Interacting
Prophylaxis 28.6%
Coagulopathy 14.3%
Gastrooesophageal Reflux Disease 14.3%
Myasthenia Gravis 14.3%
Nervousness 14.3%
Supplementation Therapy 14.3%
Pain 100.0%